Vanadium, Ruthenium and Copper Compounds : A New Class of Nonplatinum Metallodrugs with Anticancer Activity
Cancer is a group of diseases involving abnormal cell growth. The cells grow uncontrollably with the potential to invade and spread to other parts of the body. This disease is one of the principal death causes in the world, thus becoming a significant topic of scientific research. On the other hand,...
Guardado en:
| Autores principales: | León, Ignacio Esteban, Cadavid Vargas, Juan Fernando, Di Virgilio, Ana Laura, Etcheverry, Susana Beatriz |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/103353 http://eurekaselect.com/article/download/145071 |
| Aporte de: |
Ejemplares similares
-
Exploring pta alternatives in the development of ruthenium–arene anticancer compounds
por: Kljun, Jakob, et al.
Publicado: (2023) -
An overview of vanadium and cell signaling in potential cancer treatments
por: Ferretti, Valeria Alejandra, et al.
Publicado: (2022) -
The inhibitory effect of vanadium oxoanions on the activity of copper-zinc superoxide dismutase
por: Apella, María Cristina, et al.
Publicado: (1988) -
Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells
por: León, Ignacio Esteban, et al.
Publicado: (2014) -
Antitumoral properties of two new vanadyl(IV) complexes in osteoblasts in culture: role of apoptosis and oxidative stress
por: Molinuevo, María Silvina, et al.
Publicado: (2004)